Herrera-Martínez, A. D. et al. Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers. Endocr. Relat. Cancer 26, R157–R179 (2019).

Article  PubMed  Google Scholar 

Smolkova, B. et al. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms. Crit. Rev. Oncol. Hematol. 180, 103865 (2022).

Article  PubMed  Google Scholar 

Fassnacht, M. et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1476–1490 (2020).

Article  CAS  PubMed  Google Scholar 

Russano, M. et al. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. J. Exp. Clin. Cancer Res. 39, 95 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asa, S. L. & Mete, O. Endocrine pathology: past, present and future. Pathology 50, 111–118 (2018).

Article  PubMed  Google Scholar 

Rindi, G. et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr. Pathol. 33, 115–154 (2022). A comprehensive review on the current classification of NETs.

Article  CAS  PubMed  Google Scholar 

Asa, S. L., Mete, O., Perry, A. & Osamura, R. Y. Overview of the 2022 WHO classification of pituitary tumors. Endocr. Pathol. 33, 6–26 (2022). A recent review on the current classification of pituitary tumours.

Article  CAS  PubMed  Google Scholar 

Yeh, M. W. et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98, 1122–1129 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Minisola, S. et al. Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J. Bone Miner. Res. 37, 2315–2329 (2022).

Article  PubMed  Google Scholar 

Daly, A. F. & Beckers, A. The epidemiology of pituitary adenomas. Endocrinol. Metab. Clin. North Am. 49, 347–355 (2020).

Article  PubMed  Google Scholar 

Dasari, A. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3, 1335–1342 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Heaphy C. M. & Singhi A. D. The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres (ALT) to the evaluation of pancreatic neuroendocrine tumors (PanNETs). Hum. Pathol. 129, 11–20 (2022).

Article  CAS  PubMed  Google Scholar 

Berends, A. M. A. et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur. J. Int. Med. 51, 68–73 (2018).

Article  Google Scholar 

Lenders, J. W. M. et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J. Hypertens. 38, 1443–1456 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bancos, I. & Prete, A. Approach to the patient with adrenal incidentaloma. J. Clin. Endocrinol. Metab. 106, 3331–3353 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Angelousi, A. et al. Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocr. Relat. Cancer 24, R239–R259 (2017).

Article  PubMed  Google Scholar 

Fishbein, L. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181–193 (2017). A ground-breaking study on the molecular features of PPGL.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marini, F. et al. Genetics and epigenetics of parathyroid carcinoma. Front. Endocrinol. 13, 834362 (2022).

Article  Google Scholar 

Gaujoux, S. et al. Wnt/beta-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J. Clin. Endocrinol. Metab. 93, 4135–4140 (2008).

Article  CAS  PubMed  Google Scholar 

Nosé, V., Gill, A., Teijeiro, J. M. C., Perren, A. & Erickson, L. Overview of the 2022 WHO classification of familial endocrine tumor syndromes. Endocr. Pathol. 33, 197–227 (2022).

Article  PubMed  Google Scholar 

Brandi, M. L. et al. Multiple endocrine neoplasia type 1: latest insights. Endocr. Rev. 42, 133–170 (2021).

Article  PubMed  Google Scholar 

Ruggeri, R. M. et al. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known MEN syndrome. Endocrine 82, 480–490 (2023).

Article  CAS  PubMed  Google Scholar 

Minnetti, M. & Grossman, A. Somatic and germline mutations in NETs: implications for their diagnosis and management. Best Pract. Res. Clin. Endocrinol. Metab. 30, 115–127 (2016).

Article  CAS  PubMed  Google Scholar 

MacFarlane, J. et al. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: beyond phaeochromocytoma and paraganglioma. Clin. Endocrinol. 93, 528–538 (2020).

Article  CAS  Google Scholar 

Huang, J. et al. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482, 542–546 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matkar, S., Thiel, A. & Hua, X. Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem. Sci. 38, 394–402 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaji, H., Canaff, L., Lebrun, J. J., Goltzman, D. & Hendy, G. N. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc. Natl Acad. Sci. USA 98, 3837–3842 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong, C. et al. Two well-differentiated pancreatic neuroendocrine tumor mouse models. Cell Death Diff. 27, 269–283 (2020).

Article  CAS  Google Scholar 

Luo, J., Manning, B. D. & Cantley, L. C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell. 4, 257–262 (2003).

Article  CAS  PubMed  Google Scholar 

Segouffin-Cariou, C. & Billaud, M. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J. Biol. Chem. 275, 3568–3576 (2000).

Article  CAS  PubMed  Google Scholar 

Anastasaki, C., Orozco, P. & Gutmann, D. H. RAS and beyond: the many faces of the neurofibromatosis type 1 protein. Dis. Mod. Mech. 15, dmm049362 (2022).

Article  CAS  Google Scholar 

Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635–645 (2005).

Article  CAS  PubMed  Google Scholar 

Augert, A. et al. MAX functions as a tumor suppressor and rewires metabolism in small cell lung cancer. Cancer Cell 38, 97–114.e117 (2020).